Riccardo Laudicella

41PUBLICATIONS
87CO-AUTHORS
PharmacogenomicsPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Medical physicsMedical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (41)

|Jun 03, 2026
Is there a role for early SSTR-targeting PRRT in GEP-NET?

|May 19, 2026
The predictive role of [177Lu]Lu-PSMA-617 SPECT/CT semiquantitative parameters from the 1st RLT cycle in advanced mCRPC: a preliminary bicentric lesion-based analysis.

|Aug 28, 2025
PET/CT and Paraneoplastic Syndromes: A Comprehensive Review.

Motaz Daraghma, Yashant Aswani, Sanchay Jain

|Feb 11, 2025
The role of PSMA-based radioligand therapy in hormone-sensitive prostate cancer.

Riccardo Laudicella, Matteo Bauckneht, Irene A Burger

|Jan 28, 2025
[18F]PSMA-1007 PET/CT-based radiomics may help enhance the interpretation of bone focal uptakes in hormone-sensitive prostate cancer patients.

Matteo Bauckneht, Giovanni Pasini, Tania Di Raimondo

|May 24, 2024
Prostate-Specific Membrane Antigen Positron Emission Tomography Oncological Applications beyond Prostate Cancer in Comparison to Other Radiopharmaceuticals.

Alberto Miceli, Virginia Liberini, Giovanna Pepe

Pageof 7

Frequent Collaborators

11 joint publications

Irene Andrea Burger

10 joint publications

Pierpaolo Alongi

10 joint publications

Matteo Bauckneht

7 joint publications

Laura Evangelista